Home › Research › How common it is
The role of frailty and comorbidities in severe infections and the risk of dementia: a prospective, multicohort, observational study
Pyry N Sipilä, Jaana Pentti, Philipp Frank, Michael R Duggan, Keenan A Walker, Timo E Strandberg, Joni V Lindbohm, Mika Kivimäki. The lancet. Healthy longevity, 2026-04-09
Topic: Risk, prevention and care in population studies
Plain-language summary
Background Severe infections have been linked to an increased risk of dementia, but whether this association reflects pre-existing conditions that predispose individuals to infections and dementia remains unclear. Adjustment for frailty resulted in no statistically significant attenuation of the infection and dementia association (adjusted hazard ratio [HR] 1·54 [95% CI 1·43-1·67] for presence vs absence of severe infections before adjustment for frailty and 1·49 [1·37-1·61] after adjustment). Interpretation Frailty, comorbidities, and other age-related diseases were associated with a higher risk of dementia but did not account for the elevated dementia risk observed after severe infections.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 449,223 participants. In this multicohort study, severe infections were linked to a higher risk of dementia, and adjusting for frailty and other conditions did not explain away that link. Its stated limit: Observational; UK Biobank volunteers are healthier and 94.5% white; dementia from hospital and death records misses milder cases; residual confounding cannot be excluded.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Sipilä, P. N., Pentti, J., Frank, P., Duggan, M. R., Walker, K. A., Strandberg, T. E., et al. (2026). The role of frailty and comorbidities in severe infections and the risk of dementia: a prospective, multicohort, observational study. The lancet. Healthy longevity. https://doi.org/10.1016/j.lanhl.2026.100826
Vancouver
Sipilä PN, Pentti J, Frank P, Duggan MR, Walker KA, Strandberg TE, et al. The role of frailty and comorbidities in severe infections and the risk of dementia: a prospective, multicohort, observational study. The lancet. Healthy longevity. 2026. doi:10.1016/j.lanhl.2026.100826. PMID: 41969011.
BibTeX
@article{sipila2026-41969011,
author = {Sipilä, Pyry N and Pentti, Jaana and Frank, Philipp and Duggan, Michael R and Walker, Keenan A and Strandberg, Timo E and Lindbohm, Joni V and Kivimäki, Mika},
title = {{The role of frailty and comorbidities in severe infections and the risk of dementia: a prospective, multicohort, observational study}},
journal = {The lancet. Healthy longevity},
year = {2026},
doi = {10.1016/j.lanhl.2026.100826},
pmid = {41969011},
url = {https://doi.org/10.1016/j.lanhl.2026.100826}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Background Severe infections have been linked to an increased risk of dementia, but whether this association reflects pre-existing conditions that predispose individuals to infections and dementia remains unclear.
- Adjustment for frailty resulted in no statistically significant attenuation of the infection and dementia association (adjusted hazard ratio [HR] 1·54 [95% CI 1·43-1·67] for presence vs absence of severe infections before adjustment for frailty and 1·49 [1·37-1·61] after adjustment).
- Interpretation Frailty, comorbidities, and other age-related diseases were associated with a higher risk of dementia but did not account for the elevated dementia risk observed after severe infections.
Why it matters
In this multicohort study, severe infections were linked to a higher risk of dementia, and adjusting for frailty and other conditions did not explain away that link. Frailty and comorbidities were themselves linked to higher dementia risk, but they did not account for the raised risk seen after severe infections.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Study designcohort
- Participants449,223
- Effect sizeAdjusted hazard ratio for dementia after hospital-treated infection: 1.49 (95% CI 1.37-1.61) after adjustment for frailty
- Evidence strengthModerate
Limitations
Observational; UK Biobank volunteers are healthier and 94.5% white; dementia from hospital and death records misses milder cases; residual confounding cannot be excluded.
How this study scored 67/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 66 of the 98 points we could judge it on, which is 67 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (The lancet. Healthy longevity) |
| Journal's citation record | 1 / 4 | The Lancet Healthy Longevity: journal h-index 78 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 4 / 4 | 449,223 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 5 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 5 / 6 | Cited 23.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 5 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Mika Kivimäki: h-index 208 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 10 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41969011) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 66 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 66 of the 98 points we could judge it on is 67 out of 100. |
| Total | 67 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — Unpaywall lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in How common it is from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.